Phosphatase regulation of intercellular junctions

Tissue Barriers

Volumn 1, Issue 5, 2013, Pages

  McCole, Declan F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherens junction; Cadherins; Claudins; Occludin; Permeability; Phosphorylation; Tight junction

Indexed keywords

BETA CATENIN; CLAUDIN 1; DENSITY ENHANCED PROTEIN TYROSINE PHOSPHATASE 1; NEPHRIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; OCCLUDIN; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PLAKOGLOBIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; PROTEIN TYROSINE PHOSPHATASE SIGMA; PROTEIN ZO1; PROTEINASE ACTIVATED RECEPTOR 3; RECEPTOR FOR ACTIVATED C KINASE 1; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

CELL JUNCTION; EDEMA; ENZYME REGULATION; HUMAN; INFLAMMATION; NONHUMAN; PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW;

EID: 84937733197     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/tisb.26713     Document Type: Review

References (201)

1. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55:1512-20. PMID:16966705; http://dx.doi.org/10.1136/gut.2005.085373
2. Abbott NJ, Friedman A. Overview and introduction: the blood-brain barrier in health and disease. Epilepsia 2012; 53(Suppl 6):1-6. PMID:23134489; http://dx.doi.org/10.1111/j.1528-1167.2012.03696.x
3. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9:799-809; http://dx.doi.org/10.1038/nri2653. PMID:19855405
4. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 2011; 73:283-309; http://dx.doi.org/10.1146/annurev-physiol-012110-142150. PMID:20936941
5. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123:1777-88. PMID:8276896; http://dx.doi.org/10.1083/jcb.123.6.1777
6. Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Inazawa J, Fujimoto K, Tsukita S. Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur J Cell Biol 1997; 73:222-31. PMID:9243183
7. Mankertz J, Waller JS, Hillenbrand B, Tavalali S, Florian P, Schöneberg T, Fromm M, Schulzke JD. Gene expression of the tight junction protein occludin includes differential splicing and alternative promoter usage. Biochem Biophys Res Commun 2002; 298:657-66. PMID:12419305; http://dx.doi.org/10.1016/S0006-291X(02)02487-7
8. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997; 137:1393-401. PMID:9182670; http://dx.doi.org/10.1083/jcb.137.6.1393
9. Balda MS, Flores-Maldonado C, Cereijido M, Matter K. Multiple domains of occludin are involved in the regulation of paracellular permeability. J Cell Biochem 2000; 78:85-96. PMID:10797568; http://dx.doi.org/10.1002/(SICI)1097-4644(20000701)78:185::AID-JCB83.0.CO;2-F
10. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000; 11:4131-42. PMID:11102513; http://dx.doi.org/10.1091/mbc.11.12.4131
11. Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, Amasheh S, Saitou M, Tsukita S, Fromm M. Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 2005; 1669:34-42. PMID:15842997; http://dx.doi.org/10.1016/j.bbamem.2005.01.008
12. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141:1539-50. PMID:9647647; http://dx.doi.org/10.1083/jcb.141.7.1539
13. Rüffer C, Gerke V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 2004; 83:135-44. PMID:15260435; http://dx.doi.org/10.1078/0171-9335-00366
14. Gonçalves A, Ambrósio AF, Fernandes R. Regulation of claudins in blood-tissue barriers under physiological and pathological states. Tissue Barriers 2013; 1:e24782; http://dx.doi.org/10.4161/tisb.24782
15. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 2010; 20:142-9. PMID:20061152; http://dx.doi.org/10.1016/j.tcb.2009.12.002
16. Anderson JM, Stevenson BR, Jesaitis LA, Goodenough DA, Mooseker MS. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J Cell Biol 1988; 106:1141-9. PMID:2452168; http://dx.doi.org/10.1083/jcb.106.4.1141
17. Fanning AS, Anderson JM. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci 2009; 1165:113-20; http://dx.doi.org/10.1111/j.1749-6632.2009.04440.x. PMID:19538295
18. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-57. PMID:8608588; http://dx.doi.org/10.1016/S0092-8674(00)81279-9
19. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7:619-27. PMID:8573335; http://dx.doi.org/10.1016/0955-0674(95)80102-2
20. Gumbiner BM. Signal transduction of beta-catenin. Curr Opin Cell Biol 1995; 7:634-40. PMID:8573337; http://dx.doi.org/10.1016/0955-0674(95)80104-9
21. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988; 7:3679-84. PMID:3061804
22. Ozawa M, Nuruki K, Toyoyama H, Ohi Y. Cloning of an alternative form of plakoglobin (gamma-catenin) lacking the fourth armadillo repeat. J Biochem 1995; 118:836-40. PMID:8576101
23. Volberg T, Geiger B, Dror R, Zick Y. Modulation of intercellular adherens-type junctions and tyrosine phosphorylation of their components in RSV-transformed cultured chick lens cells. Cell Regul 1991; 2:105-20. PMID:1650581
24. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198:11-26. PMID:8199193
25. Brady-Kalnay SM, Rimm DL, Tonks NK. Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol 1995; 130:977-86. PMID:7642713; http://dx.doi.org/10.1083/jcb.130.4.977
26. Goldstein B, Macara IG. The PAR proteins: fundamental players in animal cell polarization. Dev Cell 2007; 13:609-22. PMID:17981131; http://dx.doi.org/10.1016/j.devcel.2007.10.007
27. Ohno S. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol 2001; 13:641-8. PMID:11544035; http://dx.doi.org/10.1016/S0955-0674(00)00264-7
28. Suzuki A, Hirata M, Kamimura K, Maniwa R, Yamanaka T, Mizuno K, Kishikawa M, Hirose H, Amano Y, Izumi N, et al. aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004; 14:1425-35. PMID:15324659; http://dx.doi.org/10.1016/j.cub.2004.08.021
29. Hurov JB, Watkins JL, Piwnica-Worms H. Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol 2004; 14:736-41. PMID:15084291; http://dx.doi.org/10.1016/j.cub.2004.04.007
30. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447:330-3. PMID:17507984; http://dx.doi.org/10.1038/nature05765
31. Benton R, St Johnston D. Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells. Cell 2003; 115:691-704. PMID:14675534; http://dx.doi.org/10.1016/S0092-8674(03)00938-3
32. Nekrasova O, Green KJ. Desmosome assembly and dynamics. Trends Cell Biol 2013. PMID:23891292; http://dx.doi.org/10.1016/j.tcb.2013.06.004
33. Samarin S, Nusrat A. Regulation of epithelial apical junctional complex by Rho family GTPases. [Landmark Ed]. Front Biosci (Landmark Ed) 2009; 14:1129-42. PMID:19273120; http://dx.doi.org/10.2741/3298
34. Ivanov AI, Samarin SN, Bachar M, Parkos CA, Nusrat A. Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. BMC Cell Biol 2009; 10:36. PMID:19422706; http://dx.doi.org/10.1186/1471-2121-10-36
35. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006; 7:833-46. PMID:17057753; http://dx.doi.org/10.1038/nrm2039
36. Dörfel MJ, Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol 2012; 2012:807356. PMID:22315516; http://dx.doi.org/10.1155/2012/807356
37. Barford D. Molecular mechanisms of the protein serine/threonine phosphatases. Trends Biochem Sci 1996; 21:407-12. PMID:8987393; http://dx.doi.org/10.1016/S0968-0004(96)10060-8
38. Kobor MS, Archambault J, Lester W, Holstege FC, Gileadi O, Jansma DB, Jennings EG, Kouyoumdjian F, Davidson AR, Young RA, et al. An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiae. Mol Cell 1999; 4:55-62. PMID:10445027; http://dx.doi.org/10.1016/S1097-2765(00)80187-2
39. Cohen PT. Protein phosphatase 1--targeted in many directions. J Cell Sci 2002; 115:241-56. PMID:11839776
40. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 2004; 117:699-711. PMID:15186772; http://dx.doi.org/10.1016/j.cell.2004.05.018
41. Seshacharyulu P, Pandey P, Datta K, Batra SK. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett 2013; 335:9-18; http://dx.doi.org/10.1016/j.canlet.2013.02.036. PMID:23454242
42. Moorhead GB, De Wever V, Templeton G, Kerk D. Evolution of protein phosphatases in plants and animals. Biochem J 2009; 417:401-9. PMID:19099538; http://dx.doi.org/10.1042/BJ20081986
43. Brautigan DL. Protein Ser/Thr phosphatases--the ugly ducklings of cell signalling. FEBS J 2013; 280:324-45. PMID:22519956; http://dx.doi.org/10.1111/j.1742-4658.2012.08609.x
44. Peti W, Nairn AC, Page R. Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 2013; 280:596-611. PMID:22284538; http://dx.doi.org/10.1111/j.1742-4658.2012.08509.x
45. Shima H, Hatano Y, Chun YS, Sugimura T, Zhang Z, Lee EY, Nagao M. Identification of PP1 catalytic subunit isotypes PP1 gamma 1, PP1 delta and PP1 alpha in various rat tissues. Biochem Biophys Res Commun 1993; 192:1289-96. PMID:7685164; http://dx.doi.org/10.1006/bbrc.1993.1556
46. da Cruz e Silva EF, Fox CA, Ouimet CC, Gustafson E, Watson SJ, Greengard P. Differential expression of protein phosphatase 1 isoforms in mammalian brain. J Neurosci 1995; 15:3375-89. PMID:7751917
47. Barford D, Das AK, Egloff MP. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 1998; 27:133-64. PMID:9646865; http://dx.doi.org/10.1146/annurev.biophys.27.1.133
48. Cohen PT. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58:453-508. PMID:2549856; http://dx.doi.org/10.1146/annurev.bi.58.070189.002321
49. Seth A, Sheth P, Elias BC, Rao R. Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J Biol Chem 2007; 282:11487-98. PMID:17298946; http://dx.doi.org/10.1074/jbc.M610597200
50. Traweger A, Wiggin G, Taylor L, Tate SA, Metalnikov P, Pawson T. Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. Proc Natl Acad Sci U S A 2008; 105:10402-7. PMID:18641122; http://dx.doi.org/10.1073/pnas.0804102105
51. Schumann M, Günzel D, Buergel N, Richter JF, Troeger H, May C, Fromm A, Sorgenfrei D, Daum S, Bojarski C, et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut 2012; 61:220-8; http://dx.doi.org/10.1136/gutjnl-2011-300123. PMID:21865402
52. Csortos C, Czikora I, Bogatcheva NV, Adyshev DM, Poirier C, Olah G, Verin AD. TIMAP is a positive regulator of pulmonary endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 2008; 295:L440-50. PMID:18586956; http://dx.doi.org/10.1152/ajplung.00325.2007
53. Verin AD, Patterson CE, Day MA, Garcia JG. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 1995; 269:L99-108. PMID:7631821
54. Essler M, Hermann K, Amano M, Kaibuchi K, Heesemann J, Weber PC, Aepfelbacher M. Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J Immunol 1998; 161:5640-6. PMID:9820544
55. Tung HY, Alemany S, Cohen P. The protein phosphatases involved in cellular regulation. 2. Purification, subunit structure and properties of protein phosphatases-2A0, 2A1, and 2A2 from rabbit skeletal muscle. Eur J Biochem 1985; 148:253-63. PMID:2985385; http://dx.doi.org/10.1111/j.1432-1033.1985.tb08833.x
56. Ronne H, Carlberg M, Hu GZ, Nehlin JO. Protein phosphatase 2A in Saccharomyces cerevisiae: effects on cell growth and bud morphogenesis. Mol Cell Biol 1991; 11:4876-84. PMID:1656215
57. Schönthal AH. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 2001; 170:1-13. PMID:11448528; http://dx.doi.org/10.1016/S0304-3835(01)00561-4
58. Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 1997; 22:245-51. PMID:9255065; http://dx.doi.org/10.1016/S0968-0004(97)01060-8
59. Mayer-Jaekel RE, Hemmings BA. Protein phosphatase 2A--a ménage à trois. Trends Cell Biol 1994; 4:287-91. PMID:14731592; http://dx.doi.org/10.1016/0962-8924(94)90219-4
60. Kamibayashi C, Estes R, Lickteig RL, Yang SI, Craft C, Mumby MC. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J Biol Chem 1994; 269:20139-48. PMID:8051102
61. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 2001; 13:7-16. PMID:11257442; http://dx.doi.org/10.1016/S0898-6568(00)00123-6
62. Sim AT, Scott JD. Targeting of PKA, PKC and protein phosphatases to cellular microdomains. Cell Calcium 1999; 26:209-17. PMID:10643559; http://dx.doi.org/10.1054/ceca.1999.0072
63. rd, Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 2002; 158:967-78. PMID:12196510; http://dx.doi.org/10.1083/jcb.200206114
64. Suzuki A, Yamanaka T, Hirose T, Manabe N, Mizuno K, Shimizu M, Akimoto K, Izumi Y, Ohnishi T, Ohno S. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 2001; 152:1183-96. PMID:11257119; http://dx.doi.org/10.1083/jcb.152.6.1183
65. Farshori P, Kachar B. Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol 1999; 170:147-56. PMID:10430658; http://dx.doi.org/10.1007/s002329900544
66. Simonovic I, Rosenberg J, Koutsouris A, Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2000; 2:305-15. PMID:11207587; http://dx.doi.org/10.1046/j.1462-5822.2000.00055.x
67. Sheth P, Samak G, Shull JA, Seth A, Rao R. Protein phosphatase 2A plays a role in hydrogen peroxide-induced disruption of tight junctions in Caco-2 cell monolayers. Biochem J 2009; 421:59-70. PMID:19356149; http://dx.doi.org/10.1042/BJ20081951
68. Basuroy S, Seth A, Elias B, Naren AP, Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 2006; 393:69-77. PMID:16134968; http://dx.doi.org/10.1042/BJ20050959
69. Aggarwal S, Suzuki T, Taylor WL, Bhargava A, Rao RK. Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers. Biochem J 2011; 433:51-63. PMID:20961289; http://dx.doi.org/10.1042/BJ20100249
70. Yamaya M, Sekizawa K, Masuda T, Morikawa M, Sawai T, Sasaki H. Oxidants affect permeability and repair of the cultured human tracheal epithelium. Am J Physiol 1995; 268:L284-93. PMID:7864148
71. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, Keshavarzian A. Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther 2002; 303:17-28. PMID:12235228; http://dx.doi.org/10.1124/jpet.102.037218
72. Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Critical role of the atypical lambda isoform of protein kinase C (PKC-lambda) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium. J Pharmacol Exp Ther 2005; 312:458-71. PMID:15347733; http://dx.doi.org/10.1124/jpet.104.074591
73. Wu F, Wilson JX. Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc Res 2009; 81:38-45; http://dx.doi.org/10.1093/cvr/cvn246. PMID:18791203
74. Dunagan M, Chaudhry K, Samak G, Rao RK. Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1356-64. PMID:23064762; http://dx.doi.org/10.1152/ajpgi.00526.2011
75. Caraballo JC, Yshii C, Butti ML, Westphal W, Borcherding JA, Allamargot C, Comellas AP. Hypoxia increases transepithelial electrical conductance and reduces occludin at the plasma membrane in alveolar epithelial cells via PKC-ζ and PP2A pathway. Am J Physiol Lung Cell Mol Physiol 2011; 300:L569-78. PMID:21257729; http://dx.doi.org/10.1152/ajplung.00109.2010
76. Nita-Lazar M, Rebustini I, Walker J, Kukuruzinska MA. Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res 2010; 316:1871-84. PMID:20156436; http://dx.doi.org/10.1016/j.yexcr.2010.02.008
77. Young MR, Liu SW, Meisinger J. Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins. Int J Cancer 2003; 103:38-44. PMID:12455051; http://dx.doi.org/10.1002/ijc.10772
78. Young MR, Kolesiak K, Meisinger J. Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. Int J Cancer 2002; 100:276-82. PMID:12115541; http://dx.doi.org/10.1002/ijc.10491
79. Tar K, Birukova AA, Csortos C, Bakó E, Garcia JG, Verin AD. Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation. J Cell Biochem 2004; 92:534-46. PMID:15156565; http://dx.doi.org/10.1002/jcb.20036
80. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424:391-7. PMID:12879061; http://dx.doi.org/10.1038/nature01784
81. Le Guelte A, Galan-Moya EM, Dwyer J, Treps L, Kettler G, Hebda JK, Dubois S, Auffray C, Chneiweiss H, Bidere N, et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J Cell Sci 2012; 125:4137-46. PMID:22685328; http://dx.doi.org/10.1242/jcs.108282
82. García C, Aranda J, Arnold E, Thébault S, Macotela Y, López-Casillas F, Mendoza V, Quiroz-Mercado H, Hernández-Montiel HL, Lin SH, et al. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest 2008; 118:2291-300. PMID:18497878
83. Volberg T, Zick Y, Dror R, Sabanay I, Gilon C, Levitzki A, Geiger B. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J 1992; 11:1733-42. PMID:1316270
84. de la Fuente-García MA, Nicolás JM, Freed JH, Palou E, Thomas AP, Vilella R, Vives J, Gayá A. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 1998; 91:2800-9. PMID:9531590
85. Matozaki T, Murata Y, Mori M, Kotani T, Okazawa H, Ohnishi H. Expression, localization, and biological function of the R3 subtype of receptor-type protein tyrosine phosphatases in mammals. Cell Signal 2010; 22:1811-7. PMID:20633639; http://dx.doi.org/10.1016/j.cellsig.2010.07.001
86. Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003; 28:284-93. PMID:12826400; http://dx.doi.org/10.1016/S0968-0004(03)00091-4
87. Feng GS. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res 1999; 253:47-54. PMID:10579910; http://dx.doi.org/10.1006/excr.1999.4668
88. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008; 27:179-92. PMID:18286234; http://dx.doi.org/10.1007/s10555-008-9126-y
89. Tonks NK, Neel BG. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 2001; 13:182-95. PMID:11248552; http://dx.doi.org/10.1016/S0955-0674(00)00196-4
90. Van Vactor D, O'Reilly AM, Neel BG. Genetic analysis of protein tyrosine phosphatases. Curr Opin Genet Dev 1998; 8:112-26. PMID:9529614; http://dx.doi.org/10.1016/S0959-437X(98)80070-1
91. Araki T, Nawa H, Neel BG. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 2003; 278:41677-84. PMID:12923167; http://dx.doi.org/10.1074/jbc.M306461200
92. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. Crystal structure of the tyrosine phosphatase SHP-2. Cell 1998; 92:441-50. PMID:9491886; http://dx.doi.org/10.1016/S0092-8674(00)80938-1
93. Barford D, Neel BG. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure 1998; 6:249-54. PMID:9551546; http://dx.doi.org/10.1016/S0969-2126(98)00027-6
94. Brady-Kalnay SM, Mourton T, Nixon JP, Pietz GE, Kinch M, Chen H, Brackenbury R, Rimm DL, Del Vecchio RL, Tonks NK. Dynamic interaction of PTPmu with multiple cadherins in vivo. J Cell Biol 1998; 141:287-96. PMID:9531566; http://dx.doi.org/10.1083/jcb.141.1.287
95. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 2000; 275:5983-6. PMID:10681592; http://dx.doi.org/10.1074/jbc.275.8.5983
96. Tsukatani Y, Suzuki K, Takahashi K. Loss of density-dependent growth inhibition and dissociation of alpha-catenin from E-cadherin. J Cell Physiol 1997; 173:54-63. PMID:9326449; http://dx.doi.org/10.1002/(SICI)1097-4652(199710)173:154::AID-JCP73.0.CO;2-I
97. Ozawa M, Kemler R. Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin complex. J Biol Chem 1998; 273:6166-70. PMID:9497337; http://dx.doi.org/10.1074/jbc.273.11.6166
98. Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation. Mol Biol Cell 2012; 23:4212-25. PMID:22956765; http://dx.doi.org/10.1091/mbc.E12-01-0038
99. Hatanaka K, Lanahan AA, Murakami M, Simons M. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2. PLoS One 2012; 7:e37600. PMID:22629427; http://dx.doi.org/10.1371/journal.pone.0037600
100. Grinnell KL, Casserly B, Harrington EO. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 2010; 298:L361-70. PMID:20023173; http://dx.doi.org/10.1152/ajplung.00374.2009
101. Adamson RH, Curry FE, Adamson G, Liu B, Jiang Y, Aktories K, Barth H, Daigeler A, Golenhofen N, Ness W, et al. Rho and rho kinase modulation of barrier properties: cultured endothelial cells and intact microvessels of rats and mice. J Physiol 2002; 539:295-308. PMID:11850521; http://dx.doi.org/10.1113/jphysiol.2001.013117
102. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001; 12:2711-20. PMID:11553710; http://dx.doi.org/10.1091/mbc.12.9.2711
103. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 2006; 281:2296-305. PMID:16308318; http://dx.doi.org/10.1074/jbc.M511248200
104. Puri P, Walker WH. The tyrosine phosphatase SHP2 regulates Sertoli cell junction complexes. Biol Reprod 2013; 88:59. PMID:23325809; http://dx.doi.org/10.1095/biolreprod.112.104414
105. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A 1999; 96:14559-64. PMID:10588744; http://dx.doi.org/10.1073/pnas.96.25.14559
106. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori Cag. Protein Sci 2002; 295:683-6
107. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002; 99:14428-33. PMID:12391297; http://dx.doi.org/10.1073/pnas.222375399
108. Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 1988; 263:6722-30. PMID:2834386
109. Tonks NK, Diltz CD, Fischer EH. Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 1988; 263:6731-7. PMID:2834387
110. Guan KL, Haun RS, Watson SJ, Geahlen RL, Dixon JE. Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A 1990; 87:1501-5. PMID:2154749; http://dx.doi.org/10.1073/pnas.87.4.1501
111. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992; 68:545-60. PMID:1739967; http://dx.doi.org/10.1016/0092-8674(92)90190-N
112. Woodford-Thomas TA, Rhodes JD, Dixon JE. Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J Cell Biol 1992; 117:401-14. PMID:1373143; http://dx.doi.org/10.1083/jcb.117.2.401
113. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283:1544-8. PMID:10066179; http://dx.doi.org/10.1126/science.283.5407.1544
114. Elchebly M, Cheng A, Tremblay ML. Modulation of insulin signaling by protein tyrosine phosphatases. J Mol Med (Berl) 2000; 78:473-82. PMID:11140373; http://dx.doi.org/10.1007/s001090000141
115. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002; 2:489-95. PMID:11970898; http://dx.doi.org/10.1016/S1534-5807(02)00148-X
116. Bourdeau A, Dubé N, Tremblay ML. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 2005; 17:203-9. PMID:15780598; http://dx.doi.org/10.1016/j.ceb.2005.02.001
117. Liu F, Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem J 1997; 327:139-45. PMID:9355745
118. Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 2003; 278:739-44. PMID:12424235; http://dx.doi.org/10.1074/jbc.M210194200
119. McCole DF, Truong A, Bunz M, Barrett KE. Consequences of direct versus indirect activation of epidermal growth factor receptor in intestinal epithelial cells are dictated by protein-tyrosine phosphatase 1B. J Biol Chem 2007; 282:13303-15. PMID:17339316; http://dx.doi.org/10.1074/jbc.M700424200
120. Balsamo J, Leung T, Ernst H, Zanin MK, Hoffman S, Lilien J. Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin. J Cell Biol 1996; 134:801-13. PMID:8707857; http://dx.doi.org/10.1083/jcb.134.3.801
121. Sheth P, Seth A, Atkinson KJ, Gheyi T, Kale G, Giorgianni F, Desiderio DM, Li C, Naren A, Rao R. Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Biochem J 2007; 402:291-300. PMID:17087658; http://dx.doi.org/10.1042/BJ20060665
122. Nakamura Y, Patrushev N, Inomata H, Mehta D, Urao N, Kim HW, Razvi M, Kini V, Mahadev K, Goldstein BJ, et al. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 2008; 102:1182-91. PMID:18451337; http://dx.doi.org/10.1161/CIRCRESAHA.107.167080
123. Grinnell KL, Chichger H, Braza J, Duong H, Harrington EO. Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation. Am J Respir Cell Mol Biol 2012; 46:623-32. PMID:22180868; http://dx.doi.org/10.1165/rcmb.2011-0271OC
124. Winter MC, Shasby S, Shasby DM. Compromised E-cadherin adhesion and epithelial barrier function with activation of G protein-coupled receptors is rescued by Y-to-F mutations in beta-catenin. Am J Physiol Lung Cell Mol Physiol 2008; 294:L442-8. PMID:18083766; http://dx.doi.org/10.1152/ajplung.00404.2007
125. Sachs N, Sonnenberg A. Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol 2013; 9:200-10. PMID:23338211; http://dx.doi.org/10.1038/nrneph.2012.291
126. Aoudjit L, Jiang R, Lee TH, New LA, Jones N, Takano T. Podocyte Protein, Nephrin, Is a Substrate of Protein Tyrosine Phosphatase 1B. J Signal Transduct 2011; 2011:376543. doi: 10.1155/2011/376543.
127. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG. cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci U S A 1989; 86:5257-61. PMID:2546150; http://dx.doi.org/10.1073/pnas.86.14.5257
128. Tiganis T, Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J 2007; 402:1-15. PMID:17238862; http://dx.doi.org/10.1042/BJ20061548
129. Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 2005; 25:819-29. PMID:15632081; http://dx.doi.org/10.1128/MCB.25.2.819-829.2005
130. Bettaieb A, Liu S, Xi Y, Nagata N, Matsuo K, Matsuo I, Chahed S, Bakke J, Keilhack H, Tiganis T, et al. Differential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphatase. J Biol Chem 2011; 286:9225-35; http://dx.doi.org/10.1074/jbc.M110.186148. PMID:21216966
131. Tiganis T. PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J 2013; 280:445-58; http://dx.doi.org/10.1111/j.1742-4658.2012.08563.x. PMID:22404968
132. Lorenzen JA, Dadabay CY, Fischer EH. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol 1995; 131:631-43. PMID:7593185; http://dx.doi.org/10.1083/jcb.131.3.631
133. Ibarra-Sánchez MJ, Simoncic PD, Nestel FR, Duplay P, Lapp WS, Tremblay ML. The T-cell protein tyrosine phosphatase. Semin Immunol 2000; 12:379-86. PMID:10995584; http://dx.doi.org/10.1006/smim.2000.0220
134. Lam MH, Michell BJ, Fodero-Tavoletti MT, Kemp BE, Tonks NK, Tiganis T. Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J Biol Chem 2001; 276:37700-7. PMID:11479308; http://dx.doi.org/10.1074/jbc.M105128200
135. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 1998; 18:1622-34. PMID:9488479
136. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 2005; 7:78-85. PMID:15592458; http://dx.doi.org/10.1038/ncb1209
137. van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, Tiganis T. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol 2005; 6:253-60. PMID:15696169; http://dx.doi.org/10.1038/ni1169
138. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 2002; 12:446-53. PMID:11909529; http://dx.doi.org/10.1016/S0960-9822(02)00697-8
139. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M, Shuai K. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 2002; 22:5662-8. PMID:12138178; http://dx.doi.org/10.1128/MCB.22.16.5662-5668.2002
140. You-Ten KE, Muise ES, Itié A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 1997; 186:683-93. PMID:9271584; http://dx.doi.org/10.1084/jem.186.5.683
141. Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 2004; 103:3457-64. PMID:14726372; http://dx.doi.org/10.1182/blood-2003-09-3153
142. Wiede F, Chew SH, van Vliet C, Poulton IJ, Kyparissoudis K, Sasmono T, Loh K, Tremblay ML, Godfrey DI, Sims NA, et al. Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in ptpn2-deficient mice. PLoS One 2012; 7:e36703; http://dx.doi.org/10.1371/journal.pone.0036703. PMID:22590589
143. Hassan SW, Doody KM, Hardy S, Uetani N, Cournoyer D, Tremblay ML. Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse. PLoS One 2010; 5:e8868. PMID:20111595; http://dx.doi.org/10.1371/journal.pone.0008868
144. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43:246-52; http://dx.doi.org/10.1038/ng.764. PMID:21297633
145. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, et al.; Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case Control Consortium. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-64. PMID:17554260; http://dx.doi.org/10.1038/ng2068
146. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359:2767-77. PMID:19073967; http://dx.doi.org/10.1056/NEJMoa0807917
147. Scharl M, Paul G, Weber A, Jung BC, Docherty MJ, Hausmann M, Rogler G, Barrett KE, McCole DF. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology 2009; 137:2030-40, e5. PMID:19818778; http://dx.doi.org/10.1053/j.gastro.2009.07.078
148. Scharl M, McCole DF, Weber A, Vavricka SR, Frei P, Kellermeier S, Pesch T, Fried M, Rogler G. Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut 2011; 60:189-97. PMID:21115548; http://dx.doi.org/10.1136/gut.2010.216606
149. Yu AS, Cheng MH, Angelow S, Günzel D, Kanzawa SA, Schneeberger EE, Fromm M, Coalson RD. Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol 2009; 133:111-27. PMID:19114638; http://dx.doi.org/10.1085/jgp.200810154
150. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 2010; 285:12037-46. PMID:20177070; http://dx.doi.org/10.1074/jbc.M109.064808
151. McCole DF. Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2. Ann N Y Acad Sci 2012; 1257:108-14. PMID:22671596; http://dx.doi.org/10.1111/j.1749-6632.2012.06522.x
152. Rhee I, Veillette A. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol 2012; 13:439-47. PMID:22513334; http://dx.doi.org/10.1038/ni.2246
153. Yang Q, Co D, Sommercorn J, Tonks NK. Cloning and expression of PTP-PEST. A novel, human, nontransmembrane protein tyrosine phosphatase. J Biol Chem 1993; 268:17650. PMID:8349645
154. Garton AJ, Flint AJ, Tonks NK. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol Cell Biol 1996; 16:6408-18. PMID:8887669
155. Davidson D, Veillette A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J 2001; 20:3414-26. PMID:11432829; http://dx.doi.org/10.1093/emboj/20.13.3414
156. Garton AJ, Tonks NK. PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J 1994; 13:3763-71. PMID:7520867
157. Espejo R, Rengifo-Cam W, Schaller MD, Evers BM, Sastry SK. PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells. Am J Physiol Cell Physiol 2010; 299:C454-63. PMID:20519451; http://dx.doi.org/10.1152/ajpcell.00148.2010
158. Souza CM, Davidson D, Rhee I, Gratton JP, Davis EC, Veillette A. The phosphatase PTP-PEST/PTPN12 regulates endothelial cell migration and adhesion, but not permeability, and controls vascular development and embryonic viability. J Biol Chem 2012; 287:43180-90. PMID:23105101; http://dx.doi.org/10.1074/jbc.M112.387456
159. Krueger NX, Streuli M, Saito H. Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 1990; 9:3241-52. PMID:2170109
160. Fachinger G, Deutsch U, Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 1999; 18:5948-53. PMID:10557082; http://dx.doi.org/10.1038/sj.onc.1202992
161. Bäumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006; 107:4754-62. PMID:16514057; http://dx.doi.org/10.1182/blood-2006-01-0141
162. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002; 21:4885-95. PMID:12234928; http://dx.doi.org/10.1093/emboj/cdf497
163. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 2008; 205:2929-45. PMID:19015309; http://dx.doi.org/10.1084/jem.20080406
164. Vestweber D. Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Ann N Y Acad Sci 2012; 1257:184-92. PMID:22671605; http://dx.doi.org/10.1111/j.1749-6632.2012.06558.x
165. Sui XF, Kiser TD, Hyun SW, Angelini DJ, Del Vecchio RL, Young BA, Hasday JD, Romer LH, Passaniti A, Tonks NK, et al. Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 2005; 166:1247-58. PMID:15793303; http://dx.doi.org/10.1016/S0002-9440(10)62343-7
166. Broermann A, Winderlich M, Block H, Frye M, Rossaint J, Zarbock A, Cagna G, Linnepe R, Schulte D, Nottebaum AF, et al. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J Exp Med 2011; 208:2393-401. PMID:22025303; http://dx.doi.org/10.1084/jem.20110525
167. Hermiston ML, Zikherman J, Zhu JW. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol Rev 2009; 228:288-311. PMID:19290935; http://dx.doi.org/10.1111/j.1600-065X.2008.00752.x
168. Takahashi T, Takahashi K, St John PL, Fleming PA, Tomemori T, Watanabe T, Abrahamson DR, Drake CJ, Shirasawa T, Daniel TO. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 2003; 23:1817-31. PMID:12588999; http://dx.doi.org/10.1128/MCB.23.5.1817-1831.2003
169. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 2008; 28:183-96. PMID:18249142; http://dx.doi.org/10.1016/j.immuni.2007.11.024
170. Takahashi T, Takahashi K, Mernaugh R, Drozdoff V, Sipe C, Schoecklmann H, Robert B, Abrahamson DR, Daniel TO. Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature. J Am Soc Nephrol 1999; 10:2135-45. PMID:10505690
171. Ostman A, Yang Q, Tonks NK. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci U S A 1994; 91:9680-4. PMID:7937872; http://dx.doi.org/10.1073/pnas.91.21.9680
172. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003; 161:793-804. PMID:12771128; http://dx.doi.org/10.1083/jcb.200209019
173. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011; 437:169-83. PMID:21711246; http://dx.doi.org/10.1042/BJ20110301
174. Carmeliet P, Lampugnani M-G, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98:147-57. PMID:10428027; http://dx.doi.org/10.1016/S0092-8674(00)81010-7
175. Chabot C, Spring K, Gratton JP, Elchebly M, Royal I. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol Cell Biol 2009; 29:241-53. PMID:18936167; http://dx.doi.org/10.1128/MCB.01374-08
176. Spring K, Chabot C, Langlois S, Lapointe L, Trinh NT, Caron C, Hebda JK, Gavard J, Elchebly M, Royal I. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood 2012; 120:2745-56. PMID:22898603; http://dx.doi.org/10.1182/blood-2011-12-398040
177. Sallee JL, Burridge K. Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells. J Biol Chem 2009; 284:14997-5006. PMID:19332538; http://dx.doi.org/10.1074/jbc.M901901200
178. Rao RK, Basuroy S, Rao VU, Karnaky KJ Jr., Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002; 368:471-81. PMID:12169098; http://dx.doi.org/10.1042/BJ20011804
179. Gebbink MF, Zondag GC, Koningstein GM, Feiken E, Wubbolts RW, Moolenaar WH. Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact. J Cell Biol 1995; 131:251-60. PMID:7559782; http://dx.doi.org/10.1083/jcb.131.1.251
180. Aricescu AR, Hon WC, Siebold C, Lu W, van der Merwe PA, Jones EY. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion. EMBO J 2006; 25:701-12. PMID:16456543; http://dx.doi.org/10.1038/sj.emboj.7600974
181. Gebbink MF, Zondag GC, Wubbolts RW, Beijersbergen RL, van Etten I, Moolenaar WH. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J Biol Chem 1993; 268:16101-4. PMID:8393854
182. Mourton T, Hellberg CB, Burden-Gulley SM, Hinman J, Rhee A, Brady-Kalnay SM. The PTPmu protein-tyrosine phosphatase binds and recruits the scaffolding protein RACK1 to cell-cell contacts. J Biol Chem 2001; 276:14896-901. PMID:11278757; http://dx.doi.org/10.1074/jbc.M010823200
183. Johnson KG, Van Vactor D. Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 2003; 83:1-24. PMID:12506125
184. Ensslen-Craig SE, Brady-Kalnay SM. PTP mu expression and catalytic activity are required for PTP mu-mediated neurite outgrowth and repulsion. Mol Cell Neurosci 2005; 28:177-88. PMID:15607952; http://dx.doi.org/10.1016/j.mcn.2004.08.011
185. Bianchi E, Bender JR, Blasi F, Pardi R. Through and beyond the wall: late steps in leukocyte transendothelial migration. Immunol Today 1997; 18:586-91. PMID:9425737; http://dx.doi.org/10.1016/S0167-5699(97)01162-6
186. Koop EA, Lopes SM, Feiken E, Bluyssen HA, van der Valk M, Voest EE, Mummery CL, Moolenaar WH, Gebbink MF. Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. Int J Dev Biol 2003; 47:345-54. PMID:12895029
187. Chagnon MJ, Uetani N, Tremblay ML. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem Cell Biol 2004; 82:664-75. PMID:15674434; http://dx.doi.org/10.1139/o04-120
188. Pulido R, Serra-Pagès C, Tang M, Streuli M. The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc Natl Acad Sci U S A 1995; 92:11686-90. PMID:8524829; http://dx.doi.org/10.1073/pnas.92.25.11686
189. Chien PN, Ryu SE. Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation. Mol Neurobiol 2013; 47:220-7. PMID:22956273; http://dx.doi.org/10.1007/s12035-012-8346-x
190. Persson C, Sjöblom T, Groen A, Kappert K, Engström U, Hellman U, Heldin CH, den Hertog J, Ostman A. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 2004; 101:1886-91. PMID:14762163; http://dx.doi.org/10.1073/pnas.0304403101
191. Wallace MJ, Batt J, Fladd CA, Henderson JT, Skarnes W, Rotin D. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma. Nat Genet 1999; 21:334-8. PMID:10080192; http://dx.doi.org/10.1038/6866
192. Muise AM, Walters T, Wine E, Griffiths AM, Turner D, Duerr RH, Regueiro MD, Ngan BY, Xu W, Sherman PM, et al. Protein-tyrosine phosphatase sigma is associated with ulcerative colitis. Curr Biol 2007; 17:1212-8. PMID:17614280; http://dx.doi.org/10.1016/j.cub.2007.06.013
193. Wagner J, Gordon LA, Heng HH, Tremblay ML, Olsen AS. Physical mapping of receptor type protein tyrosine phosphatase sigma (PTPRS) to human chromosome 19p13.3. Genomics 1996; 38:76-8. PMID:8954782; http://dx.doi.org/10.1006/geno.1996.0594
194. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66:1863-70. PMID:10777714; http://dx.doi.org/10.1086/302913
195. Batt J, Cutz E, Fladd C, Rotin D. Apparent normal lung architecture in protein tyrosine phosphatase-sigma-deficient mice. Am J Physiol Lung Cell Mol Physiol 2003; 284:L214-23. PMID:12471016
196. Müller T, Choidas A, Reichmann E, Ullrich A. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 1999; 274:10173-83. PMID:10187801; http://dx.doi.org/10.1074/jbc.274.15.10173
197. Marrs JA, Nelson WJ. Cadherin cell adhesion molecules in differentiation and embryogenesis. Int Rev Cytol 1996; 165:159-205. PMID:8900959; http://dx.doi.org/10.1016/S0074-7696(08)62222-6
198. Huber O, Bierkamp C, Kemler R. Cadherins and catenins in development. Curr Opin Cell Biol 1996; 8:685-91. PMID:8939663; http://dx.doi.org/10.1016/S0955-0674(96)80110-4
199. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845-52. PMID:8033105
200. Birchmeier W, Hülsken J, Behrens J. E-cadherin as an invasion suppressor. Ciba Found Symp 1995; 189:124-36; discussion 136-41, 174-6.
201. Scharl M, Rudenko I, McCole DF. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion. Am J Physiol Gastrointest Liver Physiol 2010; 299:G935-45. PMID:20689057; http://dx.doi.org/10.1152/ajpgi.00106.2010